MO
MOBXW
MOBIX LABS, INC
$0.0998
-50.10%
$1.3M
No data for this timeframe.
Vol
Market Cap$1.3M
Cap SizeNano Cap
Inst. Holders1 funds
Inst. Value$27.00
Inst. Activity0 buys / 1 sells
SEC Reports2
Recent Activity
May 19, 2026
SEC
Mobix Labs fully converted a $4M senior secured convertible note held by Leviston Resources into 2,500,000 common shares
8-K — Impact 7/10
May 8, 2026
SEC
Mobix Labs' S-1 registration statement (File No. 333-295357) was declared effective by the SEC on May 7, 2026. This clea
EFFECT — Impact 5/10
Inst.
UBS Group AG — NEAR_EXIT
304 shares ($27.00)
Inst.
UBS Group AG — TRIM
1,296 shares ($130.00)
Latest Reports
BEARISH
8-K
7/10
Mobix Labs fully converted a $4M senior secured convertible note held by Leviston Resources into 2,500,000 common shares
May 19, 2026
NEUTRAL
EFFECT
5/10
Mobix Labs' S-1 registration statement (File No. 333-295357) was declared effective by the SEC on May 7, 2026. This clea
May 8, 2026
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| UBS Group AG | $27.00 | NEAR_EXIT |
1 institutional holders with $27.00 total value (304 shares) as of 2025-Q3. Top holders: UBS. Net selling activity: 1 institutions trimmed/exited vs 0 added.
Top Institutional Holders — 2025-Q3
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | UBS Group AG | 304 | $27.00 | 100.0% | NEAR_EXIT -76.5% |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| UBS Group AG | NEAR_EXIT | 1,296 | 304 | -76.5% | $27.00 | 2025-Q3 |
| UBS Group AG | TRIM | 2,059 | 1,296 | -37.1% | $130.00 | 2025-Q2 |
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
2 SEC filing reports analyzed. Sentiment: 0 bullish, 1 bearish, 0 mixed, 1 neutral. Avg impact: 6.0/10.
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Current FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.